• Viral Induction of RIPK3 Degradation Modulates Necroptosis

  2026-06-13

  Liu et al. (2021) identified a viral strategy wherein orthopoxviruses induce proteasomal degradation of the necroptosis adaptor RIPK3, thereby suppressing necroptosis and modulating inflammation. This mechanism clarifies how viruses exploit the host ubiquitin-proteasome system to evade immune responses, with implications for disease modeling and antiviral research.

• Phosbind Acrylamide: Streamlining Protein Phosphorylation An

  2026-06-12

  Phos binding reagent (Phosbind) acrylamide from APExBIO enables precise, antibody-free detection of protein phosphorylation states via SDS-PAGE. This reagent empowers researchers to dissect kinase signaling with high resolution and facilitates troubleshooting in phosphorylation-dependent workflows.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-06-12

  The referenced study demonstrates that naturally occurring angiotensin peptides, including truncated forms such as Angiotensin 1/2 (5-7), significantly enhance SARS-CoV-2 spike protein binding to AXL, a lesser-known viral entry receptor. These findings reveal a mechanistic link between the renin-angiotensin system and viral pathogenesis, with implications for both hypertension and COVID-19 research.

• Rotavirus-Induced Downregulation of Nrf2 and Redox Defense P

  2026-06-11

  This study reveals how progressive rotavirus infection leads to the suppression of the redox-sensitive transcription factor Nrf2 and its downstream antioxidant genes, clarifying the dynamic regulation of host redox balance during viral infection. The findings have important implications for designing mechanistic studies on oxidative stress, viral pathogenesis, and host defense adaptation.

• SCH772984: Redefining Selective ERK1/2 Inhibition in Tumor P

  2026-06-11

  Explore how SCH772984, a potent ERK1/2 inhibitor, revolutionizes MAPK/ERK pathway inhibition in advanced tumor models. This article offers unique, in-depth analysis linking mechanistic insights to practical assay design.

• PEI-Modified Laminarin Nanoparticles Enhance Vaccine Immunit

  2026-06-10

  This study introduces polyethyleneimine-modified laminarin (CLam) nanoparticles as a novel vaccine adjuvant, significantly boosting antigen-specific humoral and cellular immune responses compared to conventional adjuvants. The research provides mechanistic insights into how surface charge and nanoparticle engineering can improve dendritic cell uptake, lysosomal escape, and antigen cross-presentation.

• ATRX Loss Sensitizes High-Grade Glioma to RTK/PDGFR Inhibiti

  2026-06-10

  The referenced study demonstrates that high-grade glioma cells lacking ATRX are markedly more sensitive to multi-targeted RTK and PDGFR inhibitors. This finding highlights ATRX status as a potential predictive biomarker for targeted therapy response and suggests new avenues for improving therapeutic strategies in aggressive gliomas.

• Lymphodepleting Chemotherapy Enhances Neoantigen T Cell Ther

  2026-06-09

  Sagie et al. reveal that lymphodepleting chemotherapy, specifically the combination of cyclophosphamide and fludarabine, substantially augments neoantigen-targeted adoptive T cell therapy by remodeling the tumor antigenic landscape and boosting antigen presentation. This mechanistic synergy informs strategies to overcome current barriers in solid tumor immunotherapy and optimize T cell therapeutics.

• Estradiol Benzoate: Optimizing Estrogen Receptor Alpha Agoni

  2026-06-09

  Estradiol Benzoate enables precise interrogation of estrogen receptor alpha signaling pathways, powering both classical and next-generation hormone receptor binding assays. Discover actionable protocols, advanced applications, and troubleshooting strategies that leverage the high purity and solubility of APExBIO’s trusted reagent.

• Protein A/G Magnetic Beads for Antibody Purification and IP

  2026-06-08

  Protein A/G Magnetic Beads enable efficient, low-background antibody purification and robust immunoprecipitation from complex biological samples. These recombinant Protein A and Protein G beads facilitate protein-protein interaction analysis, with minimized non-specific binding. APExBIO's K1305 product is validated for key immunological workflows.

• AZD0156: Advanced ATM Kinase Inhibitor for DNA Repair Studie

  2026-06-08

  AZD0156 enables precise interrogation of ATM-mediated DNA damage response and reveals unique metabolic vulnerabilities in cancer cells. This guide translates reference-backed findings into actionable workflows, troubleshooting tips, and comparative insights for maximizing experimental success with APExBIO's highly selective ATM kinase inhibitor.

• Septin4 Accelerates HIF-1α Degradation and Cardiomyocyte Apo

  2026-06-07

  This study reveals that Septin4 promotes apoptosis in hypoxia-exposed cardiomyocytes by enhancing the VHL-mediated degradation of the cardio-protective factor HIF-1α. These findings provide mechanistic insight into myocardial injury under hypoxic conditions and suggest potential therapeutic avenues targeting the HIF pathway.

• ATRX Loss Sensitizes Glioma to RTK/PDGFR Inhibitors: Insight

  2026-06-06

  Pladevall-Morera et al. identify that high-grade glioma cells lacking the chromatin remodeler ATRX are more vulnerable to receptor tyrosine kinase (RTK) and PDGFR inhibitors. Their systematic drug screening and mechanistic assays suggest ATRX status as a critical factor for interpreting targeted therapy responses and designing combinatorial treatment strategies.

• Streptavidin-FITC (SKU K1081): Reliable Biotin Detection in

  2026-06-05

  This article addresses key challenges in cell-based assays and demonstrates how Streptavidin-FITC (SKU K1081) delivers reproducible, high-sensitivity detection of biotinylated molecules. Scenario-driven insights guide biomedical researchers in protocol optimization, troubleshooting, and vendor selection, with evidence-backed recommendations for integrating this reagent into advanced workflows.

• Phenytoin in Sodium Channel Modulation: Applied Protocols &

  2026-06-05

  Phenytoin (5,5-diphenylimidazolidine-2,4-dione) stands out as a high-purity, DMSO-soluble tool for sodium channel modulation research and enzyme inhibition assays. This guide bridges reference findings and advanced workflows, offering actionable troubleshooting advice for consistent, reproducible results in electrophysiology and neurological disease modeling.

15545 records 1/1037 page Next 12345 下5页 Last page